375 related articles for article (PubMed ID: 9554869)
1. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
2. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
5. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa.
Maïga O; Djimdé AA; Hubert V; Renard E; Aubouy A; Kironde F; Nsimba B; Koram K; Doumbo OK; Le Bras J; Clain J
J Infect Dis; 2007 Jul; 196(1):165-72. PubMed ID: 17538897
[TBL] [Abstract][Full Text] [Related]
6. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
7. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum.
Chen GX; Mueller C; Wendlinger M; Zolg JW
Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892
[TBL] [Abstract][Full Text] [Related]
8. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
9. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
[TBL] [Abstract][Full Text] [Related]
10. Insights into antifolate resistance from malarial DHFR-TS structures.
Yuvaniyama J; Chitnumsub P; Kamchonwongpaisan S; Vanichtanankul J; Sirawaraporn W; Taylor P; Walkinshaw MD; Yuthavong Y
Nat Struct Biol; 2003 May; 10(5):357-65. PubMed ID: 12704428
[TBL] [Abstract][Full Text] [Related]
11. Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum.
Tarnchompoo B; Sirichaiwat C; Phupong W; Intaraudom C; Sirawaraporn W; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y
J Med Chem; 2002 Mar; 45(6):1244-52. PubMed ID: 11881993
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
13. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
[TBL] [Abstract][Full Text] [Related]
14. Stoichiometric selection of tight-binding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase.
Kamchonwongpaisan S; Vanichtanankul J; Tarnchompoo B; Yuvaniyama J; Taweechai S; Yuthavong Y
Anal Chem; 2005 Mar; 77(5):1222-7. PubMed ID: 15732900
[TBL] [Abstract][Full Text] [Related]
15. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
[TBL] [Abstract][Full Text] [Related]
18. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
19. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
[TBL] [Abstract][Full Text] [Related]
20. [Gene point mutation in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum].
Zhang ZX; Yang YM; Liu H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):87-9. PubMed ID: 12571992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
